Thomas J Kipps

Return to Grants

Awards as PI

Program Type	Institution	Grant Title	Award Value
Clinical Trial Stage Projects	University of California, San Diego	A Phase 1b/2a Study of the ROR1-Targeting Monoclonal Antibody, Cirmtuzumab, and the Bruton Tyrosine Kinase Inhibitor, Ibrutinib, in B-Cell Cancers	$18,292,674
Late Stage Preclinical Projects	University of California, San Diego	Late Stage Pre-Clinical Development of a Cirmtuzumab Based CAR T-cell for the Treatment of ROR1+ Hematological Malignancies	$1,630,360
Disease Team Therapy Development III	University of California, San Diego	Therapeutic Eradication of Cancer Stem Cells with UC-961 (Cirmtuzumab)	$4,179,598
			Total: $24,102,632.00